Loading…
Fluorouracil exacerbates alpha-crystallin B chain—mediated cell migration in triple-negative breast cancer cell lines
Among triple-negative breast cancer (TNBC) subtypes, the basal-like 2 (BL2) subtype shows the lowest survival rate and the highest risk of metastasis after treatment with chemotherapy. Research has shown that αB-crystallin ( CRYAB ) is more highly expressed in the basal-like subtypes than in the oth...
Saved in:
Published in: | Scientific reports 2023-03, Vol.13 (1), p.4010-4010, Article 4010 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c492t-a02968e933d9f7574e91340a937eb00590a9e236b42cc5cf77fb9b62a49433e63 |
container_end_page | 4010 |
container_issue | 1 |
container_start_page | 4010 |
container_title | Scientific reports |
container_volume | 13 |
creator | Yang, Lili Haga, Yuya Nishimura, Akihide Tsujii, Yuki Tanahashi, Suzuno Tsujino, Hirofumi Higashisaka, Kazuma Tsutsumi, Yasuo |
description | Among triple-negative breast cancer (TNBC) subtypes, the basal-like 2 (BL2) subtype shows the lowest survival rate and the highest risk of metastasis after treatment with chemotherapy. Research has shown that αB-crystallin (
CRYAB
) is more highly expressed in the basal-like subtypes than in the other subtypes and is associated with brain metastasis in TNBC patients. We therefore hypothesized that αB-crystallin is associated with increased cell motility in the BL2 subtype after treatment with chemotherapy. Here, we evaluated the effect of fluorouracil (5-FU), a typical chemotherapy for the treatment of TNBC, on cell motility by utilizing a cell line with high αB-crystallin expression (HCC1806). A wound healing assay revealed that 5-FU significantly increased cell motility in HCC1806 cells, but not in MDA-MB-231 cells, which have low αB-crystallin expression. Also, cell motility was not increased by 5-FU treatment in HCC1806 cells harboring stealth siRNA targeting
CRYAB
. In addition, the cell motility of MDA-MB-231 cells overexpressing αB-crystallin was significantly higher than that of MDA-MB-231 cells harboring a control vector. Thus, 5-FU increased cell motility in cell lines with high, but not low, αB-crystallin expression. These results suggest that 5-FU–induced cell migration is mediated by αB-crystallin in the BL2 subtype of TNBC. |
doi_str_mv | 10.1038/s41598-023-31186-7 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_08c64ebfaea94190aa9278480ca503b6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_08c64ebfaea94190aa9278480ca503b6</doaj_id><sourcerecordid>2786096497</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-a02968e933d9f7574e91340a937eb00590a9e236b42cc5cf77fb9b62a49433e63</originalsourceid><addsrcrecordid>eNp9ks9uFSEUh4nR2ObaF3BhJnHjZpR_wwwro43VJk3c6Jqc4Z65lxsuXGGmtTsfwif0SWQ6tbYuZAOBjw_4cQh5zuhrRkX3JkvW6K6mXNSCsU7V7SNyzKlsai44f3xvfEROct7R0hquJdNPyZFQnda0ocfk6sxPMcUpgXW-wu9gMfUwYq7AH7ZQ23SdR_Dehep9Zbfgwq8fP_e4doVZVxa9r_Zuk2B0MVQFGpM7eKwDbsrUJVZ9QshjZSEU8cIXF-Zn5MkAPuPJbb8iX88-fDn9VF98_nh--u6itlLzsQbKtepQC7HWQ9u0EjUTkoIWLfblQboMkQvVS25tY4e2HXrdKw5SSyFQiRU5X7zrCDtzSG4P6dpEcOZmIqaNgTQ669HQziqJ_QAIc0wUQPO2kx210FDRz663i-sw9SUCi2FM4B9IH64EtzWbeGlYyV6xrimGV7eGFL9NmEezd3kOBQLGKZtynqJaSd0W9OU_6K78UihZzVTTUC3L368IXyibYs4Jh7vbMGrmOjFLnZjCmps6MbP6xf133G35UxUFEAuQy1LYYPp79n-0vwH0Q8qa</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2785509402</pqid></control><display><type>article</type><title>Fluorouracil exacerbates alpha-crystallin B chain—mediated cell migration in triple-negative breast cancer cell lines</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Full-Text Journals in Chemistry (Open access)</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Yang, Lili ; Haga, Yuya ; Nishimura, Akihide ; Tsujii, Yuki ; Tanahashi, Suzuno ; Tsujino, Hirofumi ; Higashisaka, Kazuma ; Tsutsumi, Yasuo</creator><creatorcontrib>Yang, Lili ; Haga, Yuya ; Nishimura, Akihide ; Tsujii, Yuki ; Tanahashi, Suzuno ; Tsujino, Hirofumi ; Higashisaka, Kazuma ; Tsutsumi, Yasuo</creatorcontrib><description>Among triple-negative breast cancer (TNBC) subtypes, the basal-like 2 (BL2) subtype shows the lowest survival rate and the highest risk of metastasis after treatment with chemotherapy. Research has shown that αB-crystallin (
CRYAB
) is more highly expressed in the basal-like subtypes than in the other subtypes and is associated with brain metastasis in TNBC patients. We therefore hypothesized that αB-crystallin is associated with increased cell motility in the BL2 subtype after treatment with chemotherapy. Here, we evaluated the effect of fluorouracil (5-FU), a typical chemotherapy for the treatment of TNBC, on cell motility by utilizing a cell line with high αB-crystallin expression (HCC1806). A wound healing assay revealed that 5-FU significantly increased cell motility in HCC1806 cells, but not in MDA-MB-231 cells, which have low αB-crystallin expression. Also, cell motility was not increased by 5-FU treatment in HCC1806 cells harboring stealth siRNA targeting
CRYAB
. In addition, the cell motility of MDA-MB-231 cells overexpressing αB-crystallin was significantly higher than that of MDA-MB-231 cells harboring a control vector. Thus, 5-FU increased cell motility in cell lines with high, but not low, αB-crystallin expression. These results suggest that 5-FU–induced cell migration is mediated by αB-crystallin in the BL2 subtype of TNBC.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-023-31186-7</identifier><identifier>PMID: 36899050</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>5-Fluorouracil ; 631/67/1347 ; 631/80/84 ; alpha-Crystallin B Chain - genetics ; Breast cancer ; Cell adhesion & migration ; Cell Line, Tumor ; Cell migration ; Cell Movement ; Chemotherapy ; Crystallin ; Fluorouracil ; Humanities and Social Sciences ; Humans ; Metastases ; Metastasis ; Motility ; multidisciplinary ; Science ; Science (multidisciplinary) ; siRNA ; Survival ; Triple Negative Breast Neoplasms - metabolism ; Tumor cell lines ; Wound healing</subject><ispartof>Scientific reports, 2023-03, Vol.13 (1), p.4010-4010, Article 4010</ispartof><rights>The Author(s) 2023</rights><rights>2023. The Author(s).</rights><rights>The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c492t-a02968e933d9f7574e91340a937eb00590a9e236b42cc5cf77fb9b62a49433e63</cites><orcidid>0000-0001-9473-8302</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2785509402/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2785509402?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74997</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36899050$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Lili</creatorcontrib><creatorcontrib>Haga, Yuya</creatorcontrib><creatorcontrib>Nishimura, Akihide</creatorcontrib><creatorcontrib>Tsujii, Yuki</creatorcontrib><creatorcontrib>Tanahashi, Suzuno</creatorcontrib><creatorcontrib>Tsujino, Hirofumi</creatorcontrib><creatorcontrib>Higashisaka, Kazuma</creatorcontrib><creatorcontrib>Tsutsumi, Yasuo</creatorcontrib><title>Fluorouracil exacerbates alpha-crystallin B chain—mediated cell migration in triple-negative breast cancer cell lines</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Among triple-negative breast cancer (TNBC) subtypes, the basal-like 2 (BL2) subtype shows the lowest survival rate and the highest risk of metastasis after treatment with chemotherapy. Research has shown that αB-crystallin (
CRYAB
) is more highly expressed in the basal-like subtypes than in the other subtypes and is associated with brain metastasis in TNBC patients. We therefore hypothesized that αB-crystallin is associated with increased cell motility in the BL2 subtype after treatment with chemotherapy. Here, we evaluated the effect of fluorouracil (5-FU), a typical chemotherapy for the treatment of TNBC, on cell motility by utilizing a cell line with high αB-crystallin expression (HCC1806). A wound healing assay revealed that 5-FU significantly increased cell motility in HCC1806 cells, but not in MDA-MB-231 cells, which have low αB-crystallin expression. Also, cell motility was not increased by 5-FU treatment in HCC1806 cells harboring stealth siRNA targeting
CRYAB
. In addition, the cell motility of MDA-MB-231 cells overexpressing αB-crystallin was significantly higher than that of MDA-MB-231 cells harboring a control vector. Thus, 5-FU increased cell motility in cell lines with high, but not low, αB-crystallin expression. These results suggest that 5-FU–induced cell migration is mediated by αB-crystallin in the BL2 subtype of TNBC.</description><subject>5-Fluorouracil</subject><subject>631/67/1347</subject><subject>631/80/84</subject><subject>alpha-Crystallin B Chain - genetics</subject><subject>Breast cancer</subject><subject>Cell adhesion & migration</subject><subject>Cell Line, Tumor</subject><subject>Cell migration</subject><subject>Cell Movement</subject><subject>Chemotherapy</subject><subject>Crystallin</subject><subject>Fluorouracil</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Motility</subject><subject>multidisciplinary</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>siRNA</subject><subject>Survival</subject><subject>Triple Negative Breast Neoplasms - metabolism</subject><subject>Tumor cell lines</subject><subject>Wound healing</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks9uFSEUh4nR2ObaF3BhJnHjZpR_wwwro43VJk3c6Jqc4Z65lxsuXGGmtTsfwif0SWQ6tbYuZAOBjw_4cQh5zuhrRkX3JkvW6K6mXNSCsU7V7SNyzKlsai44f3xvfEROct7R0hquJdNPyZFQnda0ocfk6sxPMcUpgXW-wu9gMfUwYq7AH7ZQ23SdR_Dehep9Zbfgwq8fP_e4doVZVxa9r_Zuk2B0MVQFGpM7eKwDbsrUJVZ9QshjZSEU8cIXF-Zn5MkAPuPJbb8iX88-fDn9VF98_nh--u6itlLzsQbKtepQC7HWQ9u0EjUTkoIWLfblQboMkQvVS25tY4e2HXrdKw5SSyFQiRU5X7zrCDtzSG4P6dpEcOZmIqaNgTQ669HQziqJ_QAIc0wUQPO2kx210FDRz663i-sw9SUCi2FM4B9IH64EtzWbeGlYyV6xrimGV7eGFL9NmEezd3kOBQLGKZtynqJaSd0W9OU_6K78UihZzVTTUC3L368IXyibYs4Jh7vbMGrmOjFLnZjCmps6MbP6xf133G35UxUFEAuQy1LYYPp79n-0vwH0Q8qa</recordid><startdate>20230310</startdate><enddate>20230310</enddate><creator>Yang, Lili</creator><creator>Haga, Yuya</creator><creator>Nishimura, Akihide</creator><creator>Tsujii, Yuki</creator><creator>Tanahashi, Suzuno</creator><creator>Tsujino, Hirofumi</creator><creator>Higashisaka, Kazuma</creator><creator>Tsutsumi, Yasuo</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9473-8302</orcidid></search><sort><creationdate>20230310</creationdate><title>Fluorouracil exacerbates alpha-crystallin B chain—mediated cell migration in triple-negative breast cancer cell lines</title><author>Yang, Lili ; Haga, Yuya ; Nishimura, Akihide ; Tsujii, Yuki ; Tanahashi, Suzuno ; Tsujino, Hirofumi ; Higashisaka, Kazuma ; Tsutsumi, Yasuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-a02968e933d9f7574e91340a937eb00590a9e236b42cc5cf77fb9b62a49433e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>5-Fluorouracil</topic><topic>631/67/1347</topic><topic>631/80/84</topic><topic>alpha-Crystallin B Chain - genetics</topic><topic>Breast cancer</topic><topic>Cell adhesion & migration</topic><topic>Cell Line, Tumor</topic><topic>Cell migration</topic><topic>Cell Movement</topic><topic>Chemotherapy</topic><topic>Crystallin</topic><topic>Fluorouracil</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Motility</topic><topic>multidisciplinary</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>siRNA</topic><topic>Survival</topic><topic>Triple Negative Breast Neoplasms - metabolism</topic><topic>Tumor cell lines</topic><topic>Wound healing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Lili</creatorcontrib><creatorcontrib>Haga, Yuya</creatorcontrib><creatorcontrib>Nishimura, Akihide</creatorcontrib><creatorcontrib>Tsujii, Yuki</creatorcontrib><creatorcontrib>Tanahashi, Suzuno</creatorcontrib><creatorcontrib>Tsujino, Hirofumi</creatorcontrib><creatorcontrib>Higashisaka, Kazuma</creatorcontrib><creatorcontrib>Tsutsumi, Yasuo</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Lili</au><au>Haga, Yuya</au><au>Nishimura, Akihide</au><au>Tsujii, Yuki</au><au>Tanahashi, Suzuno</au><au>Tsujino, Hirofumi</au><au>Higashisaka, Kazuma</au><au>Tsutsumi, Yasuo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fluorouracil exacerbates alpha-crystallin B chain—mediated cell migration in triple-negative breast cancer cell lines</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2023-03-10</date><risdate>2023</risdate><volume>13</volume><issue>1</issue><spage>4010</spage><epage>4010</epage><pages>4010-4010</pages><artnum>4010</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Among triple-negative breast cancer (TNBC) subtypes, the basal-like 2 (BL2) subtype shows the lowest survival rate and the highest risk of metastasis after treatment with chemotherapy. Research has shown that αB-crystallin (
CRYAB
) is more highly expressed in the basal-like subtypes than in the other subtypes and is associated with brain metastasis in TNBC patients. We therefore hypothesized that αB-crystallin is associated with increased cell motility in the BL2 subtype after treatment with chemotherapy. Here, we evaluated the effect of fluorouracil (5-FU), a typical chemotherapy for the treatment of TNBC, on cell motility by utilizing a cell line with high αB-crystallin expression (HCC1806). A wound healing assay revealed that 5-FU significantly increased cell motility in HCC1806 cells, but not in MDA-MB-231 cells, which have low αB-crystallin expression. Also, cell motility was not increased by 5-FU treatment in HCC1806 cells harboring stealth siRNA targeting
CRYAB
. In addition, the cell motility of MDA-MB-231 cells overexpressing αB-crystallin was significantly higher than that of MDA-MB-231 cells harboring a control vector. Thus, 5-FU increased cell motility in cell lines with high, but not low, αB-crystallin expression. These results suggest that 5-FU–induced cell migration is mediated by αB-crystallin in the BL2 subtype of TNBC.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>36899050</pmid><doi>10.1038/s41598-023-31186-7</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-9473-8302</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2045-2322 |
ispartof | Scientific reports, 2023-03, Vol.13 (1), p.4010-4010, Article 4010 |
issn | 2045-2322 2045-2322 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_08c64ebfaea94190aa9278480ca503b6 |
source | Open Access: PubMed Central; Publicly Available Content Database; Full-Text Journals in Chemistry (Open access); Springer Nature - nature.com Journals - Fully Open Access |
subjects | 5-Fluorouracil 631/67/1347 631/80/84 alpha-Crystallin B Chain - genetics Breast cancer Cell adhesion & migration Cell Line, Tumor Cell migration Cell Movement Chemotherapy Crystallin Fluorouracil Humanities and Social Sciences Humans Metastases Metastasis Motility multidisciplinary Science Science (multidisciplinary) siRNA Survival Triple Negative Breast Neoplasms - metabolism Tumor cell lines Wound healing |
title | Fluorouracil exacerbates alpha-crystallin B chain—mediated cell migration in triple-negative breast cancer cell lines |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T00%3A01%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fluorouracil%20exacerbates%20alpha-crystallin%20B%20chain%E2%80%94mediated%20cell%20migration%20in%20triple-negative%20breast%20cancer%20cell%20lines&rft.jtitle=Scientific%20reports&rft.au=Yang,%20Lili&rft.date=2023-03-10&rft.volume=13&rft.issue=1&rft.spage=4010&rft.epage=4010&rft.pages=4010-4010&rft.artnum=4010&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-023-31186-7&rft_dat=%3Cproquest_doaj_%3E2786096497%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c492t-a02968e933d9f7574e91340a937eb00590a9e236b42cc5cf77fb9b62a49433e63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2785509402&rft_id=info:pmid/36899050&rfr_iscdi=true |